medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
The
growing
availability
of
pre-trained
polygenic
risk
score
(PRS)
models
has
enabled
their
integration
into
real-world
applications,
reducing
the
need
for
extensive
data
labeling,
training,
and
calibration.
However,
selecting
most
suitable
PRS
model
a
specific
target
population
remains
challenging,
due
to
issues
such
as
limited
transferability,
het-erogeneity,
scarcity
observed
phenotype
in
settings.
Ensemble
learning
offers
promising
avenue
enhance
predictive
accuracy
genetic
assessments,
but
existing
methods
often
rely
on
or
additional
genome-wide
association
studies
(GWAS)
from
optimize
ensemble
weights,
limiting
utility
real-time
implementation.
Here,
we
present
UN
supervised
en
Semble
(
UNSemblePRS
),
an
unsupervised
framework,
that
combines
without
requiring
summaries
population.
Unlike
traditional
approaches,
aggregates
based
prediction
concordance
across
curated
subset
candidate
models.
We
evaluated
using
both
continuous
binary
traits
All
Us
database,
demonstrating
its
scalability
robust
performance
diverse
populations.
These
results
underscore
accessible
tool
integrating
contexts,
offering
broad
applicability
continues
expand.
Nature,
Journal Year:
2023,
Volume and Issue:
618(7966), P. 774 - 781
Published: May 17, 2023
Abstract
Polygenic
scores
(PGSs)
have
limited
portability
across
different
groupings
of
individuals
(for
example,
by
genetic
ancestries
and/or
social
determinants
health),
preventing
their
equitable
use
1–3
.
PGS
has
typically
been
assessed
using
a
single
aggregate
population-level
statistic
R
2
)
4
,
ignoring
inter-individual
variation
within
the
population.
Here,
large
and
diverse
Los
Angeles
biobank
5
(ATLAS,
n
=
36,778)
along
with
UK
Biobank
6
(UKBB,
487,409),
we
show
that
accuracy
decreases
individual-to-individual
continuum
7
in
all
considered
populations,
even
traditionally
labelled
‘homogeneous’
ancestries.
The
decreasing
trend
is
well
captured
continuous
measure
distance
(GD)
from
training
data:
Pearson
correlation
−0.95
between
GD
averaged
84
traits.
When
applying
models
trained
on
as
white
British
UKBB
to
European
ATLAS,
furthest
decile
14%
lower
relative
closest
decile;
notably,
Hispanic
Latino
American
similar
performance
significantly
correlated
estimates
themselves
for
82
traits,
further
emphasizing
importance
incorporating
interpretation.
Our
results
highlight
need
move
away
discrete
ancestry
clusters
towards
when
considering
PGSs.
Cell Genomics,
Journal Year:
2023,
Volume and Issue:
3(1), P. 100241 - 100241
Published: Jan. 1, 2023
Polygenic
risk
scores
(PRSs)
have
been
widely
explored
in
precision
medicine.
However,
few
studies
thoroughly
investigated
their
best
practices
global
populations
across
different
diseases.
We
here
utilized
data
from
Global
Biobank
Meta-analysis
Initiative
(GBMI)
to
explore
methodological
considerations
and
PRS
performance
9
biobanks
for
14
disease
endpoints.
Specifically,
we
constructed
PRSs
using
pruning
thresholding
(P
+
T)
PRS-continuous
shrinkage
(CS).
For
both
methods,
a
European-based
linkage
disequilibrium
(LD)
reference
panel
resulted
comparable
or
higher
prediction
accuracy
compared
with
several
other
non-European-based
panels.
PRS-CS
overall
outperformed
the
classic
P
T
method,
especially
endpoints
SNP-based
heritability.
Notably,
is
heterogeneous
endpoints,
biobanks,
ancestries,
asthma,
which
has
known
variation
prevalence
populations.
Overall,
provide
lessons
construction,
evaluation,
interpretation
GBMI
resources
highlight
importance
of
biobank-scale
genomics
era.
Genome Medicine,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Feb. 19, 2024
Abstract
Polygenic
scores
(PGS)
can
be
used
for
risk
stratification
by
quantifying
individuals’
genetic
predisposition
to
disease,
and
many
potentially
clinically
useful
applications
have
been
proposed.
Here,
we
review
the
latest
potential
benefits
of
PGS
in
clinic
challenges
implementation.
could
augment
through
combined
use
with
traditional
factors
(demographics,
disease-specific
factors,
family
history,
etc.),
support
diagnostic
pathways,
predict
groups
therapeutic
benefits,
increase
efficiency
clinical
trials.
However,
there
exist
maximizing
utility
PGS,
including
FAIR
(Findable,
Accessible,
Interoperable,
Reusable)
standardized
sharing
genomic
data
needed
develop
recalculate
equitable
performance
across
populations
ancestries,
generation
robust
reproducible
calculations,
responsible
communication
interpretation
results.
We
outline
how
these
may
overcome
analytically
more
diverse
as
well
highlight
sustained
community
efforts
achieve
equitable,
impactful,
healthcare.
Cell Genomics,
Journal Year:
2024,
Volume and Issue:
4(4), P. 100523 - 100523
Published: March 19, 2024
Polygenic
risk
scores
(PRSs)
are
an
emerging
tool
to
predict
the
clinical
phenotypes
and
outcomes
of
individuals.
We
propose
PRSmix,
a
framework
that
leverages
PRS
corpus
target
trait
improve
prediction
accuracy,
PRSmix+,
which
incorporates
genetically
correlated
traits
better
capture
human
genetic
architecture
for
47
32
diseases/traits
in
European
South
Asian
ancestries,
respectively.
PRSmix
demonstrated
mean
accuracy
improvement
1.20-fold
(95%
confidence
interval
[CI],
[1.10;
1.3];
p
=
9.17
×
10
The Hastings Center Report,
Journal Year:
2023,
Volume and Issue:
53(S1)
Published: March 1, 2023
Abstract
In
this
consensus
report
by
a
diverse
group
of
academics
who
conduct
and/or
are
concerned
about
social
and
behavioral
genomics
(SBG)
research,
the
authors
recount
often‐ugly
history
scientific
attempts
to
understand
genetic
contributions
human
behaviors
outcomes.
They
then
describe
what
current
science—including
genomewide
association
studies
polygenic
indexes—can
cannot
tell
us,
as
well
its
risks
potential
benefits.
conclude
with
discussion
responsible
behavior
in
context
SBG
research.
research
that
compares
individuals
within
according
“sensitive”
phenotype
requires
extra
attention
communication
findings.
(1)
on
sensitive
phenotypes
(2)
two
or
more
groups
defined
(a)
race,
(b)
ethnicity,
(c)
ancestry
(where
could
easily
be
misunderstood
race
ethnicity)
compelling
justification
conducted,
funded,
published.
All
agree
at
least
convincing
argument
study's
design
yield
scientifically
valid
results;
some
would
additionally
require
study
have
socially
favorable
risk‐benefit
profile
.
Human Reproduction Update,
Journal Year:
2024,
Volume and Issue:
30(5), P. 529 - 557
Published: May 28, 2024
The
genetic
composition
of
embryos
generated
by
in
vitro
fertilization
(IVF)
can
be
examined
with
preimplantation
testing
(PGT).
Until
recently,
PGT
was
limited
to
detecting
single-gene,
high-risk
pathogenic
variants,
large
structural
and
aneuploidy.
Recent
advances
have
made
genome-wide
genotyping
IVF
feasible
affordable,
raising
the
possibility
screening
for
their
risk
polygenic
diseases
such
as
breast
cancer,
hypertension,
diabetes,
or
schizophrenia.
Despite
a
heated
debate
around
this
new
technology,
called
embryo
(PES;
also
PGT-P),
it
is
already
available
patients
some
countries.
Several
articles
studied
epidemiological,
clinical,
ethical
perspectives
on
PES;
however,
comprehensive,
principled
review
emerging
field
missing.
Annual Review of Biomedical Data Science,
Journal Year:
2023,
Volume and Issue:
6(1), P. 105 - 127
Published: April 26, 2023
Admixed
populations
constitute
a
large
portion
of
global
human
genetic
diversity,
yet
they
are
often
left
out
genomics
analyses.
This
exclusion
is
problematic,
as
it
leads
to
disparities
in
the
understanding
structure
and
history
diverse
cohorts
performance
genomic
medicine
across
populations.
have
particular
statistical
challenges,
inherit
segments
from
multiple
source
populations-the
primary
reason
historically
been
excluded
studies.
In
recent
years,
however,
an
increasing
number
methods
software
tools
developed
account
for
leverage
admixture
context
Here,
we
provide
survey
such
computational
strategies
informed
consideration
allow
well-calibrated
inclusion
mixed
ancestry
large-scale
studies,
detail
persisting
gaps
existing
tools.